Misodomin

Misodomin may be available in the countries listed below.

Ingredient matches for Misodomin

Lovastatin

Lovastatin is reported as an ingredient of Misodomin in the following countries:

• Greece

International Drug Name Search

Vasomil

Vasomil may be available in the countries listed below.

Ingredient matches for Vasomil

Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Vasomil in the following countries:

• South Africa

International Drug Name Search

Minopen

Minopen may be available in the countries listed below.

Ingredient matches for Minopen

Minocycline

Minocycline hydrochloride (a derivative of Minocycline) is reported as an ingredient of Minopen in the following countries:

• Japan

International Drug Name Search

Denileukin diftitox

In the US, Denileukin Diftitox (denileukin diftitox systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Lymphoma.

US matches:

• Denileukin Diftitox


• Denileukin diftitox Intravenous

Ingredient matches for Denileukin Diftitox

Denileukin Diftitox

Denileukin Diftitox (BAN, USAN) is known as Denileukin Diftitox in the US.

International Drug Name Search

Glossary

BAN	British Approved Name
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Ramipril HCT Aristo

Ramipril HCT Aristo may be available in the countries listed below.

Ingredient matches for Ramipril HCT Aristo

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Ramipril HCT Aristo in the following countries:

• Germany

Ramipril

Ramipril is reported as an ingredient of Ramipril HCT Aristo in the following countries:

• Germany

International Drug Name Search

Calbo

Calbo may be available in the countries listed below.

Ingredient matches for Calbo

Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Calbo in the following countries:

• Bangladesh

International Drug Name Search

Zymar

In the US, Zymar (gatifloxacin ophthalmic) is a member of the drug class ophthalmic anti-infectives and is used to treat Conjunctivitis, Conjunctivitis - Bacterial and Ophthalmic Surgery.

US matches:

• Zymar Drops


• Zymar


• Zymar eent

Ingredient matches for Zymar

Gatifloxacin

Gatifloxacin is reported as an ingredient of Zymar in the following countries:

• Brazil


• Canada


• Chile


• Israel


• Singapore


• South Africa


• Thailand

Gatifloxacin sesquihydrate (a derivative of Gatifloxacin) is reported as an ingredient of Zymar in the following countries:

• Mexico


• United States

International Drug Name Search

Metoclopramide Injection BP

Metoclopramide Injection BP may be available in the countries listed below.

Ingredient matches for Metoclopramide Injection BP

Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Metoclopramide Injection BP in the following countries:

• Australia

International Drug Name Search

Modalim

Modalim may be available in the countries listed below.

UK matches:

• Modalim
• Modalim Tablets 100mg (SPC)

Ingredient matches for Modalim

Ciprofibrate

Ciprofibrate is reported as an ingredient of Modalim in the following countries:

• Indonesia


• Malaysia


• Netherlands


• Singapore


• United Kingdom


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sertralin-1A Pharma

Sertralin-1A Pharma may be available in the countries listed below.

Ingredient matches for Sertralin-1A Pharma

Sertraline

Sertraline is reported as an ingredient of Sertralin-1A Pharma in the following countries:

• Germany


• Poland

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralin-1A Pharma in the following countries:

• Austria


• Switzerland

International Drug Name Search

Magnésium Sulfate Renaudin

Magnésium Sulfate Renaudin may be available in the countries listed below.

Ingredient matches for Magnésium Sulfate Renaudin

Magnesium Sulfate

Magnesium Sulfate is reported as an ingredient of Magnésium Sulfate Renaudin in the following countries:

• France

International Drug Name Search

Colludol

Colludol may be available in the countries listed below.

Ingredient matches for Colludol

Hexamidine

Hexamidine is reported as an ingredient of Colludol in the following countries:

• Luxembourg

Hexamidine diisetionate (a derivative of Hexamidine) is reported as an ingredient of Colludol in the following countries:

• Belgium


• France

Lidocaine

Lidocaine is reported as an ingredient of Colludol in the following countries:

• Luxembourg

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Colludol in the following countries:

• Belgium


• France

International Drug Name Search

Aza 20

Aza 20 may be available in the countries listed below.

Ingredient matches for Aza 20

Azelaic Acid

Azelaic Acid is reported as an ingredient of Aza 20 in the following countries:

• Indonesia

International Drug Name Search

Calcium Glycerophosphate

In the US, Calcium glycerophosphate is a member of the drug class minerals and electrolytes and is used to treat Indigestion.

Ingredient matches for Calcium glycerophosphate

Calcium Glycerophosphate

Calcium glycerophosphate (JAN) is known as Calcium Glycerophosphate in the US.

International Drug Name Search

Glossary

JAN	Japanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Nuflor

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Nuflor

Florfenicol

Florfenicol is reported as an ingredient of Nuflor in the following countries:

• Australia


• Austria


• Belgium


• France


• Germany


• Ireland


• Italy


• Luxembourg


• Netherlands


• New Zealand


• Portugal


• South Africa


• Switzerland


• United States

International Drug Name Search

Glaucoval

Glaucoval may be available in the countries listed below.

Ingredient matches for Glaucoval

Brimonidine

Brimonidine tartrate (a derivative of Brimonidine) is reported as an ingredient of Glaucoval in the following countries:

• Greece

International Drug Name Search

Hexoral

Hexoral may be available in the countries listed below.

Ingredient matches for Hexoral

Hexetidine

Hexetidine is reported as an ingredient of Hexoral in the following countries:

• Austria


• Bulgaria


• Croatia (Hrvatska)


• Estonia


• Germany


• Latvia


• Lithuania


• Romania


• Russian Federation


• Serbia

International Drug Name Search

Romefen

Romefen may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Romefen

Ketoprofen

Ketoprofen is reported as an ingredient of Romefen in the following countries:

• Austria


• Finland


• Germany


• Norway


• Portugal


• Sweden

International Drug Name Search

Azitrox

Azitrox may be available in the countries listed below.

Ingredient matches for Azitrox

Azithromycin

Azithromycin is reported as an ingredient of Azitrox in the following countries:

• Argentina


• Bulgaria


• Czech Republic


• Estonia


• Lithuania


• Poland


• Romania


• Slovakia

International Drug Name Search

Benylin for Colds

Benylin for Colds may be available in the countries listed below.

Ingredient matches for Benylin for Colds

Ibuprofen

Ibuprofen is reported as an ingredient of Benylin for Colds in the following countries:

• South Africa

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Benylin for Colds in the following countries:

• South Africa

International Drug Name Search

Fluorométholone

Fluorométholone may be available in the countries listed below.

Ingredient matches for Fluorométholone

Fluorometholone

Fluorométholone (DCF) is known as Fluorometholone in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Folaxin

Folaxin may be available in the countries listed below.

Ingredient matches for Folaxin

Calcium Levofolinate

Calcium Levofolinate is reported as an ingredient of Folaxin in the following countries:

• Spain

Folic Acid

Folic Acid is reported as an ingredient of Folaxin in the following countries:

• Indonesia

International Drug Name Search

Lormetazepam Katwijk

Lormetazepam Katwijk may be available in the countries listed below.

Ingredient matches for Lormetazepam Katwijk

Lormetazepam

Lormetazepam is reported as an ingredient of Lormetazepam Katwijk in the following countries:

• Netherlands

International Drug Name Search

Femodette

Femodette may be available in the countries listed below.

UK matches:

• Femodette (SPC)

Ingredient matches for Femodette

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Femodette in the following countries:

• United Kingdom

Gestodene

Gestodene is reported as an ingredient of Femodette in the following countries:

• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Nasacor AQ

Nasacor AQ may be available in the countries listed below.

Ingredient matches for Nasacor AQ

Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Nasacor AQ in the following countries:

• Ghana


• Kenya


• Nigeria


• Zimbabwe

International Drug Name Search

Netilmicina

Netilmicina may be available in the countries listed below.

Ingredient matches for Netilmicina

Netilmicin

Netilmicina (DCIT) is known as Netilmicin in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Alovir

Alovir may be available in the countries listed below.

Ingredient matches for Alovir

Acyclovir

Aciclovir is reported as an ingredient of Alovir in the following countries:

• Italy

International Drug Name Search

Caltrate 600+D

Ingredient matches for Caltrate 600+D

Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Caltrate 600+D in the following countries:

• Canada


• United States

Colecalciferol

Colecalciferol is reported as an ingredient of Caltrate 600+D in the following countries:

• Canada


• United States

International Drug Name Search

Dronedarone

Pronunciation: droe-NE-da-rone
Generic Name: Dronedarone
Brand Name: Multaq

Dronedarone should not be used in patients with severe (class IV) heart failure. It should also not be used in patients with mild to moderate (class II or III) heart failure who have recently had worsening symptoms that required hospitalization or special treatment. The risk of death may be increased in these patients.

Dronedarone is used for:

Decreasing the risk of needing to go to the hospital for heart problems. It is intended for use in certain patients who have had an irregular heartbeat called atrial fibrillation (AF) or atrial flutter (AFL) within the past 6 months.

Dronedarone is an antiarrhythmic. Exactly how it works is not known.

Do NOT use Dronedarone if:

• you are allergic to any ingredient in Dronedarone


• you have severe (class IV) heart failure


• you have mild to moderate (class II or III) heart failure and have recently had worsening symptoms that required hospitalization or special treatment


• you have second- or third-degree heart block or sick sinus syndrome, unless you have a pacemaker


• you have a very slow heartbeat or certain other types of irregular heartbeat


• you have severe liver problems


• you are pregnant or breast-feeding


• you take another antiarrhythmic (eg, amiodarone, dofetilide, flecainide, sotalol), an azole antifungal (eg, itraconazole, ketoconazole, voriconazole), carbamazepine, cyclosporine, a hydantoin (eg, phenytoin), a macrolide antibiotic (eg, erythromycin, clarithromycin), nefazodone, nilotinib, phenobarbital, certain phenothiazines (eg, thioridazine), primidone, protease inhibitors (eg, boceprevir, ritonavir), rifamycins (eg, rifampin), St. John's wort, telithromycin, toremifene, a tricyclic antidepressant (eg, amitriptyline), or vandetanib

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dronedarone:

Some medical conditions may interact with Dronedarone. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are able to become pregnant


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of high blood pressure, a stroke, or diabetes


• if you have a history of other heart problems (eg, heart failure, irregular heartbeat other than AF and AFL), electrolyte problems (eg, low blood potassium or magnesium), liver problems, or kidney problems


• if you will be having surgery, or if you have an implanted pacemaker or defibrillator

Some MEDICINES MAY INTERACT with Dronedarone. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Antiarrhythmics (eg, amiodarone, dofetilide, flecainide, sotalol), arsenic, astemizole, azole antifungals (eg, itraconazole, ketoconazole, voriconazole), bepridil, chloroquine, cimetidine, cisapride, crizotinib, cyclosporine , diuretics (eg, furosemide, hydrochlorothiazide), domperidone, droperidol, fingolimod, halofantrine, haloperidol. iloperidone, lithium, macrolide antibiotics (eg, clarithromycin, erythromycin), maprotiline, methadone, nefazodone, nilotinib, paliperidone, pentamidine, phenothiazines (eg, thioridazine), phosphodiesterase inhibitors (eg, vardenafil), pimozide, protease inhibitors (eg, boceprevir, ritonavir), quetiapine, quinolones (eg, levofloxacin), romidepsin, serotonin receptor antagonists (eg, dolasetron), streptogramins (eg, dalfopristin, quinupristin), telithromycin, terfenadine, tetrabenazine, toremifene, trazodone, tricyclic antidepressants (eg, amitriptyline), tyrosine kinase inhibitors (eg, dasatinib), vandetanib, or ziprasidone because side effects, such as heart rhythm problems, may occur


• Carbamazepine, hydantoins (eg, phenytoin), phenobarbital, primidone, rifamycins (eg, rifampin), or St. John's wort because they may decrease Dronedarone's effectiveness


• Anticoagulants (eg, warfarin), beta-blockers (eg, propranolol), calcium channel blockers (eg, verapamil, diltiazem), dabigatran, digoxin, HMG-CoA reductase inhibitors (eg, simvastatin), selective serotonin reuptake inhibitors (SSRIs) (eg, paroxetine), sirolimus, or tacrolimus because the risk of their side effects may be increased by Dronedarone

Ask your health care provider if Dronedarone may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dronedarone:

• Dronedarone comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Dronedarone refilled.


• Take Dronedarone by mouth with the morning and evening meals, unless your doctor tells you otherwise.


• Do not eat grapefruit or drink grapefruit juice while you take Dronedarone.


• Take Dronedarone on a regular schedule to get the most benefit from it.


• Continue to take Dronedarone even if you feel well. Do not miss any doses.


• If you miss a dose of Dronedarone, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dronedarone.

Important safety information:

• Dronedarone may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Dronedarone. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Tell your doctor or dentist that you take Dronedarone before you receive any medical or dental care, emergency care, or surgery.


• Severe liver problems have been reported in some patients using Dronedarone. Tell your doctor right away if you develop symptoms of liver problems (eg, yellowing of the skin or eyes; dark urine; pale stools, nausea, vomiting, or loss of appetite; right-sided stomach pain; fever; fatigue; unexplained itching; general feeling of being unwell). Discuss any questions or concerns with your doctor.


• Women who may become pregnant must use an effective form of birth control while they take Dronedarone. Check with your doctor if you have questions about effective birth control.


• Lab tests, including electrocardiogram (ECG), blood electrolyte levels, kidney function, and liver function, may be performed while you use Dronedarone. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Dronedarone should be used with extreme caution in CHILDREN younger than 18 years; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Dronedarone may cause harm to the fetus. Avoid becoming pregnant while you use it. If you think you may be pregnant, contact your doctor right away. It is not known if Dronedarone is found in breast milk. Do not breast-feed while taking Dronedarone.

Possible side effects of Dronedarone:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; indigestion; mild stomach pain; nausea; tiredness; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; slow heartbeat; symptoms of heart failure (eg, shortness of breath; swelling of the hands or feet; sudden, unexplained weight gain; wheezing; coughing up frothy mucus at rest, at night, or after minor exercise; trouble sleeping because of breathing problems); symptoms of liver problems (eg, yellowing of the skin or eyes; dark urine; pale stools, nausea, vomiting, or loss of appetite; right-sided stomach pain; fever; fatigue; unexplained itching; general feeling of being unwell); worsening of irregular heartbeat.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dronedarone side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; severe dizziness; unusually slow pulse; weakness.

Proper storage of Dronedarone:

Store Dronedarone at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dronedarone out of the reach of children and away from pets.

General information:

• If you have any questions about Dronedarone, please talk with your doctor, pharmacist, or other health care provider.


• Dronedarone is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dronedarone. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dronedarone resources

• Dronedarone Side Effects (in more detail)
• Dronedarone Dosage
• Dronedarone Use in Pregnancy & Breastfeeding
• Dronedarone Drug Interactions
• Dronedarone Support Group
• 14 Reviews for Dronedarone - Add your own review/rating

• Dronedarone Professional Patient Advice (Wolters Kluwer)


• dronedarone Advanced Consumer (Micromedex) - Includes Dosage Information


• Dronedarone Hydrochloride Monograph (AHFS DI)


• Multaq Prescribing Information (FDA)


• Multaq Consumer Overview

Compare Dronedarone with other medications

• Atrial Fibrillation
• Atrial Flutter

Clotrimazolo FederFARMA.CO

Clotrimazolo FederFARMA.CO may be available in the countries listed below.

Ingredient matches for Clotrimazolo FederFARMA.CO

Clotrimazole

Clotrimazole is reported as an ingredient of Clotrimazolo FederFARMA.CO in the following countries:

• Italy

International Drug Name Search

Parkadina

Parkadina may be available in the countries listed below.

Ingredient matches for Parkadina

Amantadine

Amantadine is reported as an ingredient of Parkadina in the following countries:

• Portugal

International Drug Name Search

Rivarin

Rivarin may be available in the countries listed below.

Ingredient matches for Rivarin

Ribavirin

Ribavirin is reported as an ingredient of Rivarin in the following countries:

• Bangladesh

International Drug Name Search

Askaripar

Askaripar may be available in the countries listed below.

Ingredient matches for Askaripar

Piperazine

Piperazine hexahydrate (a derivative of Piperazine) is reported as an ingredient of Askaripar in the following countries:

• Turkey

International Drug Name Search

Paracetamolo ABC

Paracetamolo ABC may be available in the countries listed below.

Ingredient matches for Paracetamolo ABC

Paracetamol

Paracetamol is reported as an ingredient of Paracetamolo ABC in the following countries:

• Italy

International Drug Name Search

Acido aspartico

Acido aspartico may be available in the countries listed below.

Ingredient matches for Acido aspartico

Amino Acids

Acido aspartico (DCIT) is known as Amino Acids in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Tyason

Tyason may be available in the countries listed below.

Ingredient matches for Tyason

Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Tyason in the following countries:

• Indonesia

International Drug Name Search

Periostat

Periostat is a brand name of doxycycline, approved by the FDA in the following formulation(s):

PERIOSTAT (doxycycline hyclate - tablet; oral)

• 
  Manufacturer: GALDERMA LABS LP
  
  Approval date: February 2, 2001
  
  Strength(s): EQ 20MG BASE ^[RLD][AB]

Has a generic version of Periostat been approved?

Yes. The following products are equivalent to Periostat:

doxycycline hyclate tablet; oral

• 
  Manufacturer: COREPHARMA
  
  Approval date: May 13, 2005
  
  Strength(s): EQ 20MG BASE ^[AB]


• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: May 13, 2005
  
  Strength(s): EQ 20MG BASE ^[AB]


• 
  Manufacturer: LANNETT
  
  Approval date: November 10, 2005
  
  Strength(s): EQ 20MG BASE ^[AB]


• 
  Manufacturer: MUTUAL PHARMA
  
  Approval date: May 13, 2005
  
  Strength(s): EQ 20MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Periostat. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Periostat.

See also...

• Periostat Consumer Information (Wolters Kluwer)
• Periostat Consumer Information (Cerner Multum)
• Periostat Advanced Consumer Information (Micromedex)
• Doxycycline Consumer Information (Drugs.com)
• Doxycycline Consumer Information (Wolters Kluwer)
• Doxycycline Capsules Consumer Information (Wolters Kluwer)
• Doxycycline Hyclate Consumer Information (Wolters Kluwer)
• Doxycycline Hyclate Delayed-Release Capsules Consumer Information (Wolters Kluwer)
• Doxycycline Hyclate Delayed-Release Tablets Consumer Information (Wolters Kluwer)
• Doxycycline Kit Consumer Information (Wolters Kluwer)
• Doxycycline Monohydrate Consumer Information (Wolters Kluwer)
• Doxycycline Suspension Consumer Information (Wolters Kluwer)
• Doxycycline Syrup Consumer Information (Wolters Kluwer)
• Doxycycline Tablets Consumer Information (Wolters Kluwer)
• Doxycycline with Cleanser Consumer Information (Wolters Kluwer)
• Doxycycline Consumer Information (Cerner Multum)
• Adoxa Pak Advanced Consumer Information (Micromedex)
• Atridox Advanced Consumer Information (Micromedex)
• Vibramycin Hyclate Advanced Consumer Information (Micromedex)
• Doxycycline Advanced Consumer Information (Micromedex)
• Doxycycline Subgingival Advanced Consumer Information (Micromedex)
• Doxycycline AHFS DI Monographs (ASHP)
• Doxycycline Calcium AHFS DI Monographs (ASHP)
• Doxycycline Hyclate AHFS DI Monographs (ASHP)
• Doxycycline Hyclate eent AHFS DI Monographs (ASHP)
• Doxycycline Monohydrate AHFS DI Monographs (ASHP)

Hosoidon

Hosoidon may be available in the countries listed below.

Ingredient matches for Hosoidon

Sodium Alginate Sulfate

Sodium Alginate Sulfate is reported as an ingredient of Hosoidon in the following countries:

• Japan

International Drug Name Search

Cisplatine Hospira

Cisplatine Hospira may be available in the countries listed below.

Ingredient matches for Cisplatine Hospira

Cisplatin

Cisplatin is reported as an ingredient of Cisplatine Hospira in the following countries:

• Belgium


• Netherlands

International Drug Name Search

Monobenzone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D11AX13

CAS registry number (Chemical Abstracts Service)

0000103-16-2

Chemical Formula

C13-H12-O2

Molecular Weight

200

Therapeutic Category

Dermatological agent: Demelanizing

Chemical Name

Phenol, 4-(phenylmethoxy)-

Foreign Names

• Monobenzonum (Latin)
• Monobenzon (German)
• Monobenzone (French)
• Monobenzona (Spanish)

Generic Names

• Monobenzone (OS: USAN, DCIT)
• Monobenzone (PH: USP 32)

Brand Names

• Benoquin
  Mac, India



• Monobenzone
  Vis, Poland

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Piprine

Piprine may be available in the countries listed below.

Ingredient matches for Piprine

Piperazine

Piperazine citrate (a derivative of Piperazine) is reported as an ingredient of Piprine in the following countries:

• South Africa

International Drug Name Search

Meloxicam Apotex

Meloxicam Apotex may be available in the countries listed below.

Ingredient matches for Meloxicam Apotex

Meloxicam

Meloxicam is reported as an ingredient of Meloxicam Apotex in the following countries:

• Netherlands

International Drug Name Search

Insulin Biosulin N

Insulin Biosulin N may be available in the countries listed below.

Ingredient matches for Insulin Biosulin N

Insulin, Isophane

Insulin, Isophane is reported as an ingredient of Insulin Biosulin N in the following countries:

• Russian Federation

International Drug Name Search

Trimeperidina

Trimeperidina may be available in the countries listed below.

Ingredient matches for Trimeperidina

Trimeperidine

Trimeperidina (DCIT) is also known as Trimeperidine (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Gliatilin

Gliatilin may be available in the countries listed below.

Ingredient matches for Gliatilin

Choline Alfoscerate

Choline Alfoscerate is reported as an ingredient of Gliatilin in the following countries:

• Georgia


• Greece


• Italy


• Poland


• Russian Federation


• Vietnam

International Drug Name Search

Coli

Coli may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Coli

Colistin Sulfate

Colistin sulfate (a derivative of Colistin) is reported as an ingredient of Coli in the following countries:

• Netherlands

International Drug Name Search

Lucidril

Lucidril may be available in the countries listed below.

Ingredient matches for Lucidril

Meclofenoxate

Meclofenoxate hydrochloride (a derivative of Meclofenoxate) is reported as an ingredient of Lucidril in the following countries:

• Japan

International Drug Name Search

Doc Nifedipine

Doc Nifedipine may be available in the countries listed below.

Ingredient matches for Doc Nifedipine

Nifedipine

Nifedipine is reported as an ingredient of Doc Nifedipine in the following countries:

• Belgium


• Luxembourg

International Drug Name Search

Testosterone heptylate SERP

Testosterone heptylate SERP may be available in the countries listed below.

Ingredient matches for Testosterone heptylate SERP

Testosterone

Testosterone 17ß-enantate (a derivative of Testosterone) is reported as an ingredient of Testosterone heptylate SERP in the following countries:

• Benin


• Burkina Faso


• Cameroon


• Central African Republic


• Chad


• Congo


• Cote D'ivoire


• Gabon


• Guinea


• Madagascar


• Mali


• Mauritania


• Mauritius


• Niger


• Senegal


• Togo

International Drug Name Search

Zamhexal

Zamhexal may be available in the countries listed below.

Ingredient matches for Zamhexal

Alprazolam

Alprazolam is reported as an ingredient of Zamhexal in the following countries:

• Australia

International Drug Name Search

Nasenspray-CT

Nasenspray-CT may be available in the countries listed below.

Ingredient matches for Nasenspray-CT

Xylometazoline

Xylometazoline hydrochloride (a derivative of Xylometazoline) is reported as an ingredient of Nasenspray-CT in the following countries:

• Germany

International Drug Name Search

Médrol

Médrol may be available in the countries listed below.

Ingredient matches for Médrol

Methylprednisolone

Methylprednisolone is reported as an ingredient of Médrol in the following countries:

• Benin


• Burkina Faso


• Cameroon


• Central African Republic


• Chad


• Congo


• Cote D'ivoire


• France


• Gabon


• Guinea


• Madagascar


• Mali


• Mauritania


• Mauritius


• Niger


• Senegal


• Togo


• Tunisia


• Zaire

International Drug Name Search

Cyclosporine

In the US, Cyclosporine (cyclosporine systemic) is a member of the drug class calcineurin inhibitors and is used to treat Cogan's Syndrome, Evan's Syndrome, Graft-versus-host disease, Idiopathic Thrombocytopenic Purpura, Nephrotic Syndrome, Organ Transplant - Rejection Prophylaxis, Organ Transplant - Rejection Reversal, Pemphigoid, Pemphigus, Psoriasis, Rheumatoid Arthritis and Ulcerative Colitis - Active.

US matches:

• Cyclosporine


• Cyclosporine Capsules


• Cyclosporine Drops


• Cyclosporine Soft Gelatin Capsules


• Cyclosporine Solution


• Cyclosporine ophthalmic


• Cyclosporine Oral, Intravenous


• Cyclosporine eent


• Cyclosporine Injection


• Cyclosporine (Cyclosporin A)

Ingredient matches for Cyclosporine

Ciclosporin

Cyclosporine (USAN) is also known as Ciclosporin (Rec.INN)

International Drug Name Search

Glossary

Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Flecainide Teva

Flecainide Teva may be available in the countries listed below.

Ingredient matches for Flecainide Teva

Flecainide

Flecainide acetate (a derivative of Flecainide) is reported as an ingredient of Flecainide Teva in the following countries:

• Italy

International Drug Name Search

Fluti-K

Fluti-K may be available in the countries listed below.

Ingredient matches for Fluti-K

Fluticasone

Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Fluti-K in the following countries:

• Argentina

International Drug Name Search

Ibuprofeno Bouzen

Ibuprofeno Bouzen may be available in the countries listed below.

Ingredient matches for Ibuprofeno Bouzen

Ibuprofen

Ibuprofen is reported as an ingredient of Ibuprofeno Bouzen in the following countries:

• Argentina

International Drug Name Search

Ribomustin

Ribomustin may be available in the countries listed below.

Ingredient matches for Ribomustin

Bendamustine

Bendamustine hydrochloride (a derivative of Bendamustine) is reported as an ingredient of Ribomustin in the following countries:

• Bulgaria


• Germany


• Switzerland

International Drug Name Search

Spironolactone-Eurogenerics

Spironolactone-Eurogenerics may be available in the countries listed below.

Ingredient matches for Spironolactone-Eurogenerics

Spironolactone

Spironolactone is reported as an ingredient of Spironolactone-Eurogenerics in the following countries:

• Luxembourg

International Drug Name Search

Opium Tincture

Generic Name: morphine solution

Dosage Form: oral solution
Opium Tincture, USP (DEODORIZED) Rx only

Opium Tincture, USP (Deodorized), is for oral administration. It is freed from unpleasant odor or nauseating substances by “denarcotization” with a petroleum distillate. Opium Tincture is a clear, reddish-brown hydroalcoholic solution.

Each 100 mL contains 1 g of anhydrous morphine (represents the equivalent of 10 g of Powdered Opium, USP), alcohol, 19%, and water.

Opium has a very characteristic odor and a very bitter taste. The opiates are the most effective and prompt-acting nonspecific antidiarrheal agents.

The opiates act by enhancing tone in the long segments of longitudinal muscle and by inhibiting propulsive contraction of both circular and longitudinal muscles.

Clinical evidence indicates that the analgesic activity of opium preparations is due to their morphine content. Relatively small doses that do not produce significant analgesia are effective in controlling diarrhea. The papaverine content of the mixed alkaloids is too small to have demonstrable spasmolytic activity.

Following oral administration, morphine is well absorbed from the gastrointestinal tract. It is rapidly metabolized following oral administration, however, and plasma levels of unconjugated morphine are lower than those achieved after parenteral administration. Like other narcotic analgesics, opium preparations are metabolized in the liver. Morphine undergoes conjugation with glucuronic acid at the 3-hydroxyl group. Secondary conjugation may also occur at the 6-hydroxyl group to form the 3,6-diglucuronide.

Morphine is excreted in the urine mainly as morphine-3-glucuronide and smaller amounts of morphine-3,6-diglucuronide and unchanged drug. Approximately 75% of a dose of morphine is excreted in the urine within 48 hours.

Opium Tincture is useful for the treatment of diarrhea.

This preparation is not recommended for use in children. It should not be used in diarrhea caused by poisoning until the toxic material is eliminated from the gastrointestinal tract.

Addiction can result from opium usage. Opium preparations should be given in the smallest effective dose and as infrequently as possible to minimize the development of tolerance and physical dependence.

General - Opium should be used with caution in the elderly, in debilitated individuals, and in patients with increased intracranial pressure, cerebral arteriosclerosis, hepatic cirrhosis or liver insufficiency, gastrointestinal hemorrhage, myxedema, emphysema, and bronchial asthma.

Drug Interactions - When preparations containing opium are administered in combination with other drugs, the cautions applicable to each ingredient should be borne in mind. Reduced dosage is indicated in poor-risk patients, in the very young or very old patient, and in those who are receiving other central-nervous system depressants.

Usage in Pregnancy - Pregnancy Category C — Animal reproduction studies have not been conducted with Opium Tincture, USP (Deodorized). It is also not known whether Opium Tincture, USP (Deodorized), can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Opium Tincture, USP (Deodorized), should be given to a pregnant woman only if clearly needed.

Nursing Mothers - Caution should be exercised when Opium Tincture, USP (Deodorized), is administered to a nursing woman.

Usage in Children - Safety and effectiveness in children have not been established. See Contraindications.

Constipation, nausea, and vomiting may occur in some patients. Pruritus and urticaria have been observed.

Controlled Substance - Opium Tincture, USP (Deodorized), is a  Schedule II drug. See Warnings.

Signs and Symptoms - Symptoms of toxicity are those of morphine and alcohol, such as nausea, vomiting, miosis, cool and clammy skin, respiratory and CNS depression, bradycardia, hypotension, and skeletal muscle flaccidity. Noncardiogenic pulmonary edema may develop after opioid overdose and monitoring of heart filling pressure may be helpful. Ethanol has been demonstrated to cause hypoglycemia in children or adults with limited glycogen stores. In severe overdosage, apnea, circulatory collapse, cardiac arrest, and death may occur.

Treatment - To obtain up-to-date information about the treatment of overdose, a good resource is your certified Regional Poison Control Center. Telephone numbers of certified poison control centers are listed in the Physicians’ Desk Reference (PDR). In managing overdosage, consider the possibility of multiple drug overdoses, interaction among drugs, and unusual drug kinetics in your patient.

Initial management of opioid overdose should emphasize establishment of a secure airway and support of ventilation and perfusion. Meticulously monitor and maintain, within acceptable limits, the patient’s vital signs, blood gases, serum electrolytes, blood glucose, etc. Naloxone antagonizes most effects of opioids. Protect the airway as naloxone may induce vomiting. Since naloxone has a shorter duration of action than opioids, repeated doses may be needed. In patients who abuse opioids chronically, a withdrawal syndrome may be manifest on administration of naloxone. This may include yawning, tearing, restlessness, sweating, dilated pupils, piloerection, vomiting, diarrhea, and abdominal cramps. This syndrome usually abates quickly as the effect of naloxone dissipates.

Absorption of drugs from the gastrointestinal tract may be decreased by giving activated charcoal, which, in many cases, is more effective than emesis or lavage; consider charcoal instead of or in addition to gastric emptying. Repeated doses of charcoal over time may hasten elimination of some drugs that have been absorbed. Since Opium Tincture can delay gastric emptying, evacuation of the stomach may be beneficial. Safeguard the patient’s airway when employing gastric emptying or charcoal.

Monitor for and treat hypoglycemia.

The use of forced diuresis, peritoneal dialysis, hemodialysis, or charcoal hemoperfusion has not been established to be beneficial.

Usual Adult Dose — 0.6 mL orally 4 times a day.

Opium Tincture, USP (Deodorized), is supplied as:

Bottles of 4 fl oz  - NDC 42998-203-01

Bottles of 16 fl oz - NDC 42998-203-02

Store at controlled room temperature, 68° to 77° F (20° to 25° C) (see USP).

Manufactured for:

Marathon Pharmaceuticals, LLC

Deerfield, IL 60015 USA

by: Halo Pharmaceutical, Inc.

Whippany, NJ 07981

August 2010

0228-00

This is a representative sample of the packaging.  Please see How Supplied section for a complete list of available packaging.


Principal Display Panel - Label 4oz - OT1

label-4oz.jpg


NDC-42998-203-01

Opium Tincture USP CII

(Deodorized)

10 mg/mL

of anhydrous morphine

Rx Only

118 mL (4 fl oz)


Each 100 mL contains 1g of anhydrous morphine (represents the

equivalent of 10 g of Powdered Opium USP) and alcohol 19%

Usual Adult Dose 0.6 mL (10 min) 4 times a day

Keep Tightly Closed Dispense in a tight light-resistant container

Store at 68° to 77° F (20° to 25° C) (See USP Controlled Room Temperature)

Manufactured for Marathon Pharmaceuticals, LLC

Deerfield, IL 60015 USA

by: Halo Pharmaceuticals, Inc.

Whippany, NJ 07981

Opium Tincture (DEODORIZED)  morphine (anhydrous)  solution

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 42998-203 Route of Administration ORAL DEA Schedule CII

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Morphine (Morphine) Morphine 10 mg  in 1 mL

Inactive Ingredients Ingredient Name Strength Alcohol

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 42998-203-01 118 mL In 1 BOTTLE, GLASS None 2 42998-203-02 473 mL In 1 BOTTLE, GLASS None

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		09/25/2008

Labeler - Marathon Pharmaceuticals, LLC (828905336)

Registrant - Marathon Pharmaceuticals, LLC (828905336)

Revised: 09/2011Marathon Pharmaceuticals, LLC

More Opium Tincture resources

• Opium Tincture Dosage
• Opium Tincture Use in Pregnancy & Breastfeeding
• Drug Images
• Opium Tincture Drug Interactions
• Opium Tincture Support Group
• 146 Reviews for Opium - Add your own review/rating

Compare Opium Tincture with other medications

• Pain

Solodyn

In the US, Solodyn (minocycline systemic) is a member of the drug class tetracyclines and is used to treat Acne and Rosacea.

US matches:

• Solodyn


• Solodyn Extended-Release Tablets

Ingredient matches for Solodyn

Minocycline

Minocycline hydrochloride (a derivative of Minocycline) is reported as an ingredient of Solodyn in the following countries:

• United States

International Drug Name Search

Dilantin

Dilantin is a brand name of phenytoin, approved by the FDA in the following formulation(s):

DILANTIN-125 (phenytoin - suspension; oral)

• 
  Manufacturer: PARKE DAVIS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 125MG/5ML ^[RLD][AB]

Has a generic version of Dilantin been approved?

Yes. The following products are equivalent to Dilantin:

phenytoin suspension; oral

• 
  Manufacturer: TARO
  
  Approval date: March 8, 2004
  
  Strength(s): 125MG/5ML ^[AB]


• 
  Manufacturer: VISTAPHARM
  
  Approval date: January 31, 2001
  
  Strength(s): 125MG/5ML ^[AB]


• 
  Manufacturer: VISTAPHARM
  
  Approval date: August 18, 2005
  
  Strength(s): 125MG/5ML ^[AB]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: April 19, 2002
  
  Strength(s): 125MG/5ML ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dilantin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Dilantin.

See also...

• Dilantin Consumer Information (Drugs.com)
• Dilantin Infatabs Chewable Tablets Consumer Information (Wolters Kluwer)
• Dilantin Kapseals Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Dilantin Suspension Consumer Information (Wolters Kluwer)
• Dilantin Consumer Information (Cerner Multum)
• Dilantin Infatabs Consumer Information (Cerner Multum)
• Dilantin Kapseals Consumer Information (Cerner Multum)
• Dilantin-125 Consumer Information (Cerner Multum)
• Dilantin Advanced Consumer Information (Micromedex)
• Dilantin Infatabs Advanced Consumer Information (Micromedex)
• Dilantin Intravenous Advanced Consumer Information (Micromedex)
• Dilantin Kapseals Advanced Consumer Information (Micromedex)
• Dilantin-125 Advanced Consumer Information (Micromedex)
• Dilantin-30 Advanced Consumer Information (Micromedex)
• Phenytoin Consumer Information (Drugs.com)
• Phenytoin Consumer Information (Wolters Kluwer)
• Phenytoin Chewable Tablets Consumer Information (Wolters Kluwer)
• Phenytoin Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Phenytoin Immediate-Release Capsules Consumer Information (Wolters Kluwer)
• Phenytoin Suspension Consumer Information (Wolters Kluwer)
• Phenytoin Consumer Information (Cerner Multum)
• Diphen Advanced Consumer Information (Micromedex)
• Phenytoin Advanced Consumer Information (Micromedex)
• Phenytoin Intravenous Advanced Consumer Information (Micromedex)
• Phenytoin AHFS DI Monographs (ASHP)
• Phenytoin Sodium AHFS DI Monographs (ASHP)

Monell

Monell may be available in the countries listed below.

Ingredient matches for Monell

Domperidone

Domperidone is reported as an ingredient of Monell in the following countries:

• Indonesia

International Drug Name Search

Pollakisu

Pollakisu may be available in the countries listed below.

Ingredient matches for Pollakisu

Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Pollakisu in the following countries:

• Japan

International Drug Name Search

Salazopyrin-EN

Salazopyrin-EN may be available in the countries listed below.

Ingredient matches for Salazopyrin-EN

Sulfasalazine

Sulfasalazine is reported as an ingredient of Salazopyrin-EN in the following countries:

• Czech Republic


• Iceland


• Israel


• Norway


• Romania


• Singapore


• Sri Lanka


• Taiwan


• Thailand

International Drug Name Search

Oftaler

Oftaler may be available in the countries listed below.

Ingredient matches for Oftaler

Ketotifen

Ketotifen is reported as an ingredient of Oftaler in the following countries:

• Chile

International Drug Name Search

Saymotin S

Saymotin S may be available in the countries listed below.

Ingredient matches for Saymotin S

Kallidinogenase

Kallidinogenase is reported as an ingredient of Saymotin S in the following countries:

• Japan

International Drug Name Search

Omeprazolo Ranbaxy

Omeprazolo Ranbaxy may be available in the countries listed below.

Ingredient matches for Omeprazolo Ranbaxy

Omeprazole

Omeprazole is reported as an ingredient of Omeprazolo Ranbaxy in the following countries:

• Italy

International Drug Name Search

Dextromethorphan/Guaifenesin/Phenylephrine Liquid

Pronunciation: dex-troe-meth-OR-fan/gwye-FEN-eh-sin/fen-ill-EF-rin
Generic Name: Dextromethorphan/Guaifenesin/Phenylephrine
Brand Name: Examples include Tussidex and Zotex

Dextromethorphan/Guaifenesin/Phenylephrine Liquid is used for:

Relieving congestion, cough, and throat and airway irritation due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.

Dextromethorphan/Guaifenesin/Phenylephrine Liquid is a decongestant, cough suppressant, and expectorant combination. It works by constricting blood vessels and reducing swelling in the nasal passages, loosening mucus and lung secretions in the chest, and making coughs more productive. It also works in the brain to help decrease the cough reflex to reduce a dry cough.

Do NOT use Dextromethorphan/Guaifenesin/Phenylephrine Liquid if:

• you are allergic to any ingredient in Dextromethorphan/Guaifenesin/Phenylephrine Liquid


• you have severe high blood pressure, rapid heartbeat, or other severe heart problems (eg, heart blood vessel disease)


• you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dextromethorphan/Guaifenesin/Phenylephrine Liquid:

Some medical conditions may interact with Dextromethorphan/Guaifenesin/Phenylephrine Liquid. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of glaucoma, an enlarged prostate gland or other prostate problems, heart problems, diabetes, high blood pressure, blood vessel problems, adrenal gland problems, an overactive thyroid, seizures, or stroke


• if you have a chronic cough, lung problems (eg, asthma, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus

Some MEDICINES MAY INTERACT with Dextromethorphan/Guaifenesin/Phenylephrine Liquid. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Beta-blockers (eg, propranolol), COMT inhibitors (eg, tolcapone), furazolidone, indomethacin, MAO inhibitors (eg, phenelzine), or tricyclic antidepressants (eg, amitriptyline) because the risk of side effects from Dextromethorphan/Guaifenesin/Phenylephrine Liquid may be increased


• Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased


• Bromocriptine because the risk of side effects may be increased by Dextromethorphan/Guaifenesin/Phenylephrine Liquid


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Dextromethorphan/Guaifenesin/Phenylephrine Liquid

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dextromethorphan/Guaifenesin/Phenylephrine Liquid may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dextromethorphan/Guaifenesin/Phenylephrine Liquid:

Use Dextromethorphan/Guaifenesin/Phenylephrine Liquid as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Dextromethorphan/Guaifenesin/Phenylephrine Liquid may be taken with or without food.


• Drink plenty of water while taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Dextromethorphan/Guaifenesin/Phenylephrine Liquid, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dextromethorphan/Guaifenesin/Phenylephrine Liquid.

Important safety information:

• Dextromethorphan/Guaifenesin/Phenylephrine Liquid may cause dizziness or drowsiness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Dextromethorphan/Guaifenesin/Phenylephrine Liquid. Using Dextromethorphan/Guaifenesin/Phenylephrine Liquid alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• Do not take appetite suppressants while you are taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid without checking with your doctor.


• Dextromethorphan/Guaifenesin/Phenylephrine Liquid contains phenylephrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains phenylephrine. If it does or if you are uncertain, contact your doctor or pharmacist.


• Do NOT exceed the recommended dose or take Dextromethorphan/Guaifenesin/Phenylephrine Liquid for longer than prescribed without checking with your doctor.


• If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.


• Dextromethorphan/Guaifenesin/Phenylephrine Liquid may interfere with certain lab test results. Make sure that all of your doctors and lab personnel know that you are taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid.


• Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Dextromethorphan/Guaifenesin/Phenylephrine Liquid.


• Use Dextromethorphan/Guaifenesin/Phenylephrine Liquid with caution in the ELDERLY because they may be more sensitive to its effects.


• Caution is advised when using Dextromethorphan/Guaifenesin/Phenylephrine Liquid in CHILDREN because they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid, discuss with your doctor the benefits and risks of using Dextromethorphan/Guaifenesin/Phenylephrine Liquid during pregnancy. It is unknown if Dextromethorphan/Guaifenesin/Phenylephrine Liquid is excreted in breast milk. Do not breast-feed while taking Dextromethorphan/Guaifenesin/Phenylephrine Liquid.

Possible side effects of Dextromethorphan/Guaifenesin/Phenylephrine Liquid:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; excitability; headache; nausea; nervousness or anxiety; trouble sleeping; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dextromethorphan/Guaifenesin/Phenylephrine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.

Proper storage of Dextromethorphan/Guaifenesin/Phenylephrine Liquid:

Store Dextromethorphan/Guaifenesin/Phenylephrine Liquid at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dextromethorphan/Guaifenesin/Phenylephrine Liquid out of the reach of children and away from pets.

General information:

• If you have any questions about Dextromethorphan/Guaifenesin/Phenylephrine Liquid, please talk with your doctor, pharmacist, or other health care provider.


• Dextromethorphan/Guaifenesin/Phenylephrine Liquid is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dextromethorphan/Guaifenesin/Phenylephrine Liquid. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dextromethorphan/Guaifenesin/Phenylephrine resources

• Dextromethorphan/Guaifenesin/Phenylephrine Side Effects (in more detail)
• Dextromethorphan/Guaifenesin/Phenylephrine Use in Pregnancy & Breastfeeding
• Dextromethorphan/Guaifenesin/Phenylephrine Drug Interactions
• Dextromethorphan/Guaifenesin/Phenylephrine Support Group
• 0 Reviews for Dextromethorphan/Guaifenesin/Phenylephrine - Add your own review/rating

Compare Dextromethorphan/Guaifenesin/Phenylephrine with other medications

• Cough and Nasal Congestion

Budesonide Sustained-Release Capsules

Pronunciation: byoo-DESS-oh-nide
Generic Name: Budesonide
Brand Name: Entocort EC

Budesonide Sustained-Release Capsules are used for:

Treating mild to moderate Crohn disease and maintaining remission for up to 3 months. It may also be used for other conditions as determined by your doctor.

Budesonide Sustained-Release Capsules are a corticosteroid. It works by decreasing inflammation.

Do NOT use Budesonide Sustained-Release Capsules if:

• you are allergic to any ingredient in Budesonide Sustained-Release Capsules


• you are taking mifepristone

Contact your doctor or health care provider right away if any of these apply to you.

Before using Budesonide Sustained-Release Capsules:

Some medical conditions may interact with Budesonide Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have heart problems; diabetes; esophagus inflammation; stomach problems; intestinal problems; heart attack; ulcer; kidney problems; liver disease; osteoporosis; high blood pressure; glaucoma; cataracts; a herpes eye infection; a bacterial, fungal, parasitic, or viral infection; diarrhea; measles; tuberculosis; chicken pox; or shingles


• if you have had a positive TB skin test or have recently been vaccinated

Some MEDICINES MAY INTERACT with Budesonide Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Barbiturates (eg, phenobarbital), carbamazepine, hydantoins (eg, phenytoin), or rifampin because they may decrease Budesonide Sustained-Release Capsules's effectiveness


• Clarithromycin, steroidal contraceptives (eg, birth control pills), or imidazole antifungals (eg, ketoconazole, itraconazole) because they may increase the risk of Budesonide Sustained-Release Capsules's side effects


• Ritodrine or live vaccines because the risk of their side effects may be increased by Budesonide Sustained-Release Capsules


• Hydantoins (eg, phenytoin) because their effectiveness may be decreased by Budesonide Sustained-Release Capsules


• Mifepristone because risk of side effects may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Budesonide Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Budesonide Sustained-Release Capsules:

Use Budesonide Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Budesonide Sustained-Release Capsules. Talk to your pharmacist if you have questions about this information.


• Take Budesonide Sustained-Release Capsules by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Swallow Budesonide Sustained-Release Capsules whole. Do not break, crush, or chew before swallowing.


• Use Budesonide Sustained-Release Capsules on a regular schedule to get the most benefit from it.


• Do not eat grapefruit or drink grapefruit juice while you use Budesonide Sustained-Release Capsules.


• If you miss a dose of Budesonide Sustained-Release Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Budesonide Sustained-Release Capsules.

Important safety information:

• Budesonide Sustained-Release Capsules may cause dizziness. These effects may be worse if you take it with alcohol or certain medicines. Take Budesonide Sustained-Release Capsules with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Tell your doctor or dentist that you take Budesonide Sustained-Release Capsules before you receive any medical or dental care, emergency care, or surgery.


• Budesonide Sustained-Release Capsules may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.


• If you have not had chickenpox, shingles, or measles, avoid contact with anyone who does.


• Do not receive a live vaccine (eg, measles, mumps) while you are taking Budesonide Sustained-Release Capsules. Talk with your doctor before you receive any vaccine.


• Diabetes patients - Budesonide Sustained-Release Capsules may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Lab tests, including adrenal function assessment, may be performed while you use Budesonide Sustained-Release Capsules. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Budesonide Sustained-Release Capsules should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Budesonide Sustained-Release Capsules while you are pregnant. Budesonide Sustained-Release Capsules are found in breast milk. Do not breast-feed while taking Budesonide Sustained-Release Capsules.

Possible side effects of Budesonide Sustained-Release Capsules:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Back pain; changes in menstrual cycle; dizziness; gas; headache; indigestion; nausea; nervousness; pain; respiratory tract infection; stomach pain; tiredness; tremor; trouble sleeping; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); acne; change in mood or behavior; chest pain; confusion; severe headache; sudden increase in weight; swelling of the ankles; unusual bruising; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Budesonide Sustained-Release Capsules:

Store Budesonide Sustained-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Budesonide Sustained-Release Capsules out of the reach of children and away from pets.

General information:

• If you have any questions about Budesonide Sustained-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.


• Budesonide Sustained-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Budesonide Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Budesonide resources

• Budesonide Use in Pregnancy & Breastfeeding
• Budesonide Drug Interactions
• Budesonide Support Group
• 22 Reviews for Budesonide - Add your own review/rating

Compare Budesonide with other medications

• Asthma, Maintenance
• Autoimmune Hepatitis
• Crohn's Disease
• Crohn's Disease, Acute
• Crohn's Disease, Maintenance
• Eosinophilic Esophagitis
• Inflammatory Bowel Disease